Home » United Kingdom » Page 23

United Kingdom

Committee of the Whole – L13: Promoting international cooperation in responding to new psychoactive substances and amphetamine-type stimulants including methamphetamine

Australia – this builds on work already done on NPS. We want to offer a resolution to consolidate the work CND and member states have done on the issue. We have noticed increases in the frequency of NPS use. Other countries are experiencing similar issues. We promote international cooperation and information sharing, including on ATS. Discussions …

Read more

CND Day 1 – Agenda item 6(a): Challenges and future work of the CND and the WHO in the review of substances for possible scheduling recommendations

The goal is to assist states in applying the procedures as outlined in the three drug conventions. E/CN.7/2014/10 outlines the relevant provisions of the drug control conventions for scheduling. UNODC – By December 2014, the number of NPS reported by NPS rose to over 540 substances. The global spread of these substances have also increased …

Read more

Committee of the Whole – L.4: Supporting the availability, accessibility and diversity of evidence-based treatment and care for young people affected by drug use disorders

Title Pakistan – We recommend adding to the title, ‘Young abusers of drugs, while ensuring effective law enforcement measures and related penal provisions.’ Portugal – We request inclusion in the list of states putting forward this resolution. Netherlands – We don’t think it’s apt to introduce that kind of language [referring to Pakistan’s suggestion of a title …

Read more

CND Day 1 – Agenda item 6(b): Change in the scope of control of substances

Commission will identify the notifications in the order they were received. Begin with mephedrone recommended by the UK. Then will look at ketamine recommended by China. Then will look at reocmmendations from the WHO including (a) AH-7921 should be placed in Schedule I of the 1961 Convention; (b) gamma-Butyrolactone (GBL), 1,4-butanediol, 25B-NBOMe (2C-B-NBOMe), 25C-NBOMe (2C-C-NBOMe) …

Read more

UNGASS Special Segment Day 4 – Interactive Discussion Alternative development; regional, interregional and international cooperation on development-oriented, balanced drug control policy; addressing socioeconomic issues

UNODC Introduction. The UNGASS provides a unique opportunity to assess what work and what doesn’t when addressing the drug problem, including in the area of alternative development. Member states clearly view alternative development as a vital pillar of any strategy. One major challenge is that starting in 2009, official development assistance for alternative development has decreased, …

Read more

UNGASS Special Segment Day 3 – Interactive discussion on Cross-cutting issues: New challenges, threats and realities in preventing and addressing the world drug problem in compliance with relevant international law

UNODC Introduction – New challenges have emerged in recent years related to new harmful substances and new trafficking route, and new trafficking modus operandi. Successes can be claimed in terms of reduced illicit cultivation and improved treatment services. But, challenges remain in ensuring the right balance in reduction of both demand and supply. Some of the challenges …

Read more